(2838) Clinical Application and Validation of a Predictive Antimicrobial Resistance Risk Categorization Framework for Patients with Uncomplicated Urinary Tract Infection

Saturday, October 14, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

Ryan K. Shields, PharmD, MS

Associate Professor of Medicine
University of Pittsburgh
Pittsburgh, PA, United States
WC

Wendy Y. Cheng, MPH, PhD, ORCID: 0000-0002-8281-2496

Manager
Analysis Group, Inc
Boston, Massachusetts, United States
KK

Kalé Kponee-Shovein, ScD

Analysis Group, Inc.
Boston, Massachusetts, United States
FK

Fernando Kuwer, MSc

Analysis Group, Inc.
Boston, Massachusetts, United States
CG

Chi Gao, ScD

Analysis Group, Inc.
Boston, Massachusetts, United States
Ashish V. Joshi, PhD

Senior Director
GlaxoSmithKline plc.
Collegeville, Pennsylvania, United States
FM

Fanny S. Mitrani-Gold, MPH

Director, Epidemiology
GlaxoSmithKline plc.
Collegeville, Pennsylvania, United States
PS

Patrick Schwab, PhD

GSK
Collegeville, Pennsylvania, United States
DF

Diogo Ferrinho, PharmD

Global Medical Affairs Leader
GSK
London, England, United Kingdom
MM

Malena Mahendran, MS

Analysis Group, Inc.
Boston, Massachusetts, United States
DI

Daniel Indacochea, PhD

Analysis Group, Inc.
Boston, Massachusetts, United States
LP

Lisa Pinheiro, MFin

GSK
Boston, Massachusetts, United States
JR

Jimmy Royer, PhD

Analysis Group, Inc.
Boston, Massachusetts, United States